Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and pharmacokinetics of oseltamivir at standard and high dosages.
Dutkowski R, Smith JR, Davies BE. Dutkowski R, et al. Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1. Int J Antimicrob Agents. 2010. PMID: 20189775 Clinical Trial.
Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza.
Winther B, Block SL, Reisinger K, Dutkowski R. Winther B, et al. Among authors: dutkowski r. Int J Pediatr Otorhinolaryngol. 2010 Jun;74(6):684-8. doi: 10.1016/j.ijporl.2010.03.024. Epub 2010 Apr 3. Int J Pediatr Otorhinolaryngol. 2010. PMID: 20363510 Clinical Trial.
Safety and pharmacology of oseltamivir in clinical use.
Dutkowski R, Thakrar B, Froehlich E, Suter P, Oo C, Ward P. Dutkowski R, et al. Drug Saf. 2003;26(11):787-801. doi: 10.2165/00002018-200326110-00004. Drug Saf. 2003. PMID: 12908848 Review.
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
Ward P, Small I, Smith J, Suter P, Dutkowski R. Ward P, et al. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. doi: 10.1093/jac/dki018. J Antimicrob Chemother. 2005. PMID: 15709056 Review.
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
Toovey S, Prinssen EP, Rayner CR, Thakrar BT, Dutkowski R, Koerner A, Chu T, Sirzen-Zelenskaya A, Britschgi M, Bansod S, Donner B. Toovey S, et al. Among authors: dutkowski r. Adv Ther. 2012 Oct;29(10):826-48. doi: 10.1007/s12325-012-0050-8. Epub 2012 Oct 2. Adv Ther. 2012. PMID: 23054689 Review.
Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
Ison MG, Szakaly P, Shapira MY, Kriván G, Nist A, Dutkowski R. Ison MG, et al. Among authors: dutkowski r. Antivir Ther. 2012;17(6):955-64. doi: 10.3851/IMP2192. Epub 2012 Jun 22. Antivir Ther. 2012. PMID: 22728756 Clinical Trial.
Safety and tolerability of a 6-week course of oseltamivir prophylaxis for seasonal influenza in children.
Reisinger K, Shu D, Cupelli L, Marcadis I, Dutkowski R. Reisinger K, et al. Among authors: dutkowski r. Influenza Other Respir Viruses. 2013 Jan;7(1):11-3. doi: 10.1111/j.1750-2659.2012.00367.x. Epub 2012 Apr 23. Influenza Other Respir Viruses. 2013. PMID: 22520945 Free PMC article. Clinical Trial.
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.
Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R. Smith JR, et al. Among authors: dutkowski r. Adv Ther. 2011 Nov;28(11):927-59. doi: 10.1007/s12325-011-0072-7. Epub 2011 Nov 1. Adv Ther. 2011. PMID: 22057727 Free PMC article. Review.
Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D. Toovey S, et al. Among authors: dutkowski r. Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Drug Saf. 2008. PMID: 19026027 Review.
33 results
Jump to page
Feedback